NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.

July 19, 2024

Vol.50 No.29

By Jacquelyn Cobb

Health Equity White House

Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa

Source: Livestream of White House Africa Cancer Care ForumThe White House Cancer Moonshot is committing an additional $100 million to programs focused on reducing cancer burden in African countries.

July 19, 2024

Vol.50 No.29

By McKenzie Prillaman

In Brief

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

The National Comprehensive Cancer Network announced recognitions for the award-winning library of NCCN Guidelines for Patients and NCCN Patient Webinars.

June 21, 2024

Vol.50 No.25

Clinical Roundup

IQVIA releases 2024 global oncology trends report

The IQVIA Institute for Human Data Science has released its annual trends report, Global Oncology Trends 2024: Outlook to 2028.

May 31, 2024

Vol.50 No.22

Drugs & Targets

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy for patients in Estonia.

May 31, 2024

Vol.50 No.22

Guest Editorial

Training programs for medical educators can overcome barriers in global oncology
How an education program in Ethiopia increased access to cancer pain management

Teachers who master their craft know this secret: They will not meet some of their pupils.

May 24, 2024

Vol.50 No.21

By Ethan Dmitrovsky

NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

YOU MAY BE INTERESTED IN

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

IQVIA releases 2024 global oncology trends report

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Training programs for medical educators can overcome barriers in global oncology
How an education program in Ethiopia increased access to cancer pain management

Renew today!

Subscriber content

Login

NCCN and Polish oncology groups to adapt NCCN Guidelines for Poland

YOU MAY BE INTERESTED IN

Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa

NCCN patient resources receive Hemes Creative Award, Communicator Award, Viddy Award

IQVIA releases 2024 global oncology trends report

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Training programs for medical educators can overcome barriers in global oncologyHow an education program in Ethiopia increased access to cancer pain management

Login

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

Training programs for medical educators can overcome barriers in global oncology
How an education program in Ethiopia increased access to cancer pain management